ARS Pharmaceuticals (SPRY.US) Stock Community - Hot Topic Discussions - Longbridge

Quote List Quote List

Event Tracking

Nov10

ARS Pharmaceuticals released FY2025 Q3 earnings on November 10 Pre-Market (EST), actual revenue USD 32.5 M (forecast USD 28.68 M), actual EPS USD -0.5176 (forecast USD -0.4685)

14:30

ARS Pharmaceuticals released FY2025 9 Months Earnings on November 10 Pre-Market (EST), with actual revenue of USD 56.19 M and EPS of USD -1.32

14:30

Nov3

ARS Pharmaceuticals to Present New Real-World Data on Nasal Adrenaline Spray Neffy® at ACAAI Conference

12:45

ARS Pharmaceuticals to release FY2025 Q3 earnings on November 10, Pre-Market EST, with forecasted revenue of USD 28.87 M and EPS of USD -0.4733

00:08

Oct8

ARS Pharmaceuticals Secures NEFFY® Patent Protection Until 2039

12:10

Sep29

ARS Pharmaceuticals Secures $250 Million Financing to Enhance Product Commercialization

20:05

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 32.5 M, Net Income -51.15 M, EPS -0.5176

Aug13

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 15.72 M, Net Income -44.88 M, EPS -0.4563

May14

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 7.973 M, Net Income -33.94 M, EPS -0.3461

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More